Thomas Lehman

771 total citations
24 papers, 293 citations indexed

About

Thomas Lehman is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Thomas Lehman has authored 24 papers receiving a total of 293 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Rheumatology, 10 papers in Immunology and 7 papers in Hematology. Recurrent topics in Thomas Lehman's work include Psoriasis: Treatment and Pathogenesis (9 papers), Spondyloarthritis Studies and Treatments (7 papers) and Autoimmune and Inflammatory Disorders Research (7 papers). Thomas Lehman is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (9 papers), Spondyloarthritis Studies and Treatments (7 papers) and Autoimmune and Inflammatory Disorders Research (7 papers). Thomas Lehman collaborates with scholars based in United States, United Kingdom and Netherlands. Thomas Lehman's co-authors include Sheila T. Angeles‐Han, Thomas E. Flynn, Karen Onel, Bee Wah Lee, Robert C. Dunbar, Melanie J. Harrison, Jeffrey P. Honovich, Stephen Lyman, John R. Rutledge and Lynette Pei‐Chi Shek and has published in prestigious journals such as PEDIATRICS, The Journal of Physical Chemistry and Annals of the Rheumatic Diseases.

In The Last Decade

Thomas Lehman

24 papers receiving 282 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Lehman United States 11 143 129 100 48 35 24 293
A Urayama Japan 4 140 1.0× 19 0.1× 295 3.0× 17 0.4× 39 1.1× 10 504
Daniel L. Larson United States 11 134 0.9× 97 0.8× 9 0.1× 108 2.3× 25 0.7× 21 501
Rudolf Benz Switzerland 11 29 0.2× 188 1.5× 3 0.0× 50 1.0× 58 1.7× 36 418
Mitsuhiro Iwata Japan 13 27 0.2× 12 0.1× 17 0.2× 81 1.7× 61 1.7× 41 425
Ana Blanco Spain 9 72 0.5× 7 0.1× 73 0.7× 6 0.1× 19 0.5× 25 341
Ken Hasegawa Japan 10 14 0.1× 49 0.4× 14 0.1× 10 0.2× 53 1.5× 30 319
Gutteridge Jean-Charles United States 13 13 0.1× 27 0.2× 5 0.1× 26 0.5× 79 2.3× 26 281
Daniel Bertin France 13 100 0.7× 28 0.2× 2 0.0× 88 1.8× 59 1.7× 46 408
Farhad Shahsavar Iran 14 36 0.3× 44 0.3× 4 0.0× 297 6.2× 34 1.0× 47 449
Farrukh Shah United Kingdom 16 17 0.1× 542 4.2× 6 0.1× 9 0.2× 73 2.1× 53 894

Countries citing papers authored by Thomas Lehman

Since Specialization
Citations

This map shows the geographic impact of Thomas Lehman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Lehman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Lehman more than expected).

Fields of papers citing papers by Thomas Lehman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Lehman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Lehman. The network helps show where Thomas Lehman may publish in the future.

Co-authorship network of co-authors of Thomas Lehman

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Lehman. A scholar is included among the top collaborators of Thomas Lehman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Lehman. Thomas Lehman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mease, Philip J., Miroslawa Nowak, Jiyoon Choi, et al.. (2025). Impact of Delay of Treatment With Disease‐Modifying Antirheumatic Drugs in Psoriatic Arthritis: The CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry. ACR Open Rheumatology. 7(6). e70019–e70019. 1 indexed citations
2.
Strand, Vibeke, Laure Gossec, Laura C. Coates, et al.. (2024). Improvements in Patient‐Reported Outcomes After Treatment With Deucravacitinib in Patients With Psoriatic Arthritis: Results From a Randomized Phase 2 Trial. Arthritis Care & Research. 76(8). 1139–1148. 1 indexed citations
3.
Kavanaugh, Arthur, Laura C. Coates, Philip J. Mease, et al.. (2024). Deucravacitinib, a selective, TYK2 inhibitor, in psoriatic arthritis: achievement of minimal disease activity components in a phase 2 trial. Lara D. Veeken. 64(5). 2557–2564. 3 indexed citations
4.
Deodhar, Atul, D. van der Heijde, Jeffrey Neal, et al.. (2022). POS1048 SAFETY AND EFFICACY OF DEUCRAVACITINIB, AN ORAL, SELECTIVE TYROSINE KINASE 2 INHIBITOR, IN PATIENTS WITH PSORIATIC ARTHRITIS: 52-WEEK RESULTS FROM A RANDOMISED PHASE 2 TRIAL. Annals of the Rheumatic Diseases. 81. 842–843. 5 indexed citations
5.
6.
Harrold, Leslie R., Seán Connolly, Sheila Kelly, et al.. (2021). Baseline Anti-Citrullinated Protein Antibody Status and Response to Abatacept or Non-TNFi Biologic/Targeted-Synthetic DMARDs: US Observational Study of Patients with RA. Rheumatology and Therapy. 9(2). 465–480. 16 indexed citations
7.
Gossec, Laure, Laura C. Coates, Alexis Ogdie, et al.. (2021). AB0560 EFFECT OF DEUCRAVACITINIB ON THE PSORIATIC ARTHRITIS IMPACT OF DISEASE (PsAID) QUESTIONNAIRES 12 AND 9: ANALYSIS OF A PHASE 2 STUDY OF ACTIVE PSORIATIC ARTHRITIS. Annals of the Rheumatic Diseases. 80. 1316–1317. 1 indexed citations
8.
Strand, Vibeke, E. Alemao, Thomas Lehman, et al.. (2018). Improved patient-reported outcomes in patients with psoriatic arthritis treated with abatacept: results from a phase 3 trial. Arthritis Research & Therapy. 20(1). 269–269. 11 indexed citations
9.
Strand, Vibeke, et al.. (2017). FRI0520 Improved patient-reported outcomes in psoriatic arthritis patients treated with abatacept: results from a phase iii trial. Annals of the Rheumatic Diseases. 76. 687–687. 2 indexed citations
10.
Angeles‐Han, Sheila T., Kenneth W. Griffin, Thomas Lehman, et al.. (2010). The importance of visual function in the quality of life of children with uveitis. Journal of American Association for Pediatric Ophthalmology and Strabismus. 14(2). 163–168. 39 indexed citations
11.
Angeles‐Han, Sheila T., Thomas E. Flynn, & Thomas Lehman. (2008). Abatacept for refractory juvenile idiopathic arthritis-associated uveitis- a case report.. PubMed. 35(9). 1897–8. 63 indexed citations
12.
Lehman, Thomas, et al.. (2004). Combined intravenous methotrexate and cyclophosphamide for refractory childhood lupus nephritis. Annals of the Rheumatic Diseases. 63(3). 321–323. 22 indexed citations
13.
Lehman, Thomas. (2004). It's Not Just Growing Pains: A Guide to Childhood Muscle, Bone, and Joint Pain, Rheumatic Diseases, and the Latest Treatments. 2 indexed citations
14.
Lehman, Thomas, et al.. (2002). Thalidomide therapy for recalcitrant systemic onset juvenile rheumatoid arthritis. The Journal of Pediatrics. 140(1). 125–127. 34 indexed citations
15.
Shek, Lynette Pei‐Chi, et al.. (1999). Thalidomide Responsiveness in an Infant With Behcet's Syndrome. PEDIATRICS. 103(6). 1295–1297. 24 indexed citations
16.
Brown, Eugene W., et al.. (1985). Confusion of a poststreptococcal syndrome complicated by uveitis with mucocutaneous lymph node syndrome.. PubMed. 17(4). 259–61. 4 indexed citations
17.
Honovich, Jeffrey P., Robert C. Dunbar, & Thomas Lehman. (1985). Laser studies of energy relaxation in gas-phase ion photodissociation. The Journal of Physical Chemistry. 89(12). 2513–2517. 18 indexed citations
18.
Helrich, Carl S. & Thomas Lehman. (1979). A rolling pendulum bob: Conservation of energy and partitioning of kinetic energy. American Journal of Physics. 47(4). 367–368. 2 indexed citations
19.
Lehman, Thomas, Robert S. Peters, Virgil Hanson, & Arthur D. Schwabe. (1978). Long-term colchicine therapy of familial mediterranean fever. The Journal of Pediatrics. 93(5). 876–878. 14 indexed citations
20.
Maré, G.R. De, et al.. (1973). The vapour pressure of benzaldehyde between 273 and 376 K. The Journal of Chemical Thermodynamics. 5(6). 829–832. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A Urayama Breakdown of academic impact, for papers by Daniel L. Larson Breakdown of academic impact, for papers by Rudolf Benz Breakdown of academic impact, for papers by Mitsuhiro Iwata Breakdown of academic impact, for papers by Ana Blanco Breakdown of academic impact, for papers by Ken Hasegawa Breakdown of academic impact, for papers by Gutteridge Jean-Charles Breakdown of academic impact, for papers by Daniel Bertin Breakdown of academic impact, for papers by Farhad Shahsavar Breakdown of academic impact, for papers by Farrukh Shah
Rankless by CCL
2026